These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23101317)

  • 1. Report from the Hymenoptera Committee of the Spanish Society of Allergology and Clinical Immunology: immunotherapy with bumblebee venom.
    Cruz S; Vega A; Fernández S; Marquès L; Baltasar M; Alonso A; Jorro G; Moreno A; Sánchez-Morillas L; Miranda A; Soriano V; Fernández J; Guspi R; ;
    J Investig Allergol Clin Immunol; 2012; 22(5):377-8. PubMed ID: 23101317
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Position paper: Immunotherapy with hymenoptera venoms. (EAACI) The European Academy of Allergology and Clinical Immunology.
    Allergy; 1993; 48(14 Suppl):36-46. PubMed ID: 8342739
    [No Abstract]   [Full Text] [Related]  

  • 5. [Allergy to Hymenoptera venom in children. Diagnosis and therapy].
    Pastorello EA; Incorvaia C; Sarassi A; Qualizza R; Guidoboni A; Farioli L
    Minerva Pediatr; 1989 Aug; 41(8):419-23. PubMed ID: 2601661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
    von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
    Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there an indication for desensitization therapy (venom immunotherapy) in a transplanted child with bee venom allergy? What are the risks and chances of success?
    Ponvert C; Scheinmann P
    Pediatr Nephrol; 1997 Aug; 11(4):530. PubMed ID: 9260264
    [No Abstract]   [Full Text] [Related]  

  • 8. Bee venom allergy.
    Annila I
    Clin Exp Allergy; 2000 Dec; 30(12):1682-7. PubMed ID: 11122205
    [No Abstract]   [Full Text] [Related]  

  • 9. Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway.
    Gangemi S; Patella V; Cianci E; Saitta S; Lattanzio S; Florio G; Romano M
    Ann Allergy Asthma Immunol; 2012 Sep; 109(3):226-7. PubMed ID: 22920084
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sting challenge test in Hymenoptera venom allergy: pros and cons.
    Bilò MB; Brianzoni MF; Garritani MS; Antonicelli L; Farabollini B; Bonifazi F
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):377-81. PubMed ID: 14768522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of allergy to hymenoptera venoms.
    Hamilton RG
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):323-9. PubMed ID: 20543672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy.
    Bonadonna P; Zanotti R; Caruso B; Castellani L; Perbellini O; Colarossi S; Chilosi M; Dama A; Schiappoli M; Pizzolo G; Senna G; Passalacqua G
    J Allergy Clin Immunol; 2008 Jan; 121(1):256-7. PubMed ID: 18206512
    [No Abstract]   [Full Text] [Related]  

  • 15. Stinging insect hypersensitivity. Safety and efficacy of venom immunotherapy.
    Golub JR; Kaplan SR; Mascia AV
    N Y State J Med; 1984 Feb; 84(2):66-8. PubMed ID: 6583559
    [No Abstract]   [Full Text] [Related]  

  • 16. Humoral immunological response in patients with venom allergy during specific immunotherapy.
    Szymański W; Chyrek-Borowska S
    Rocz Akad Med Bialymst; 1995; 40(2):376-82. PubMed ID: 8834621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.
    Bernstein JA; Kagen SL; Bernstein DI; Bernstein IL
    Ann Allergy; 1994 Nov; 73(5):423-8. PubMed ID: 7978535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for hymenoptera venom hypersensitivity.
    Müller U; Golden DB; Lockey RF; Shin B
    Clin Allergy Immunol; 2008; 21():377-92. PubMed ID: 18828518
    [No Abstract]   [Full Text] [Related]  

  • 19. Higher frequency of early local side effects with aqueous versus depot immunotherapy for hymenoptera venom allergy.
    Cadario G; Marengo F; Ranghino E; Rossi R; Gatti B; Cantone R; Bona F; Pellegrino R; Feyles G; Puccinelli P; Burastero SE
    J Investig Allergol Clin Immunol; 2004; 14(2):127-33. PubMed ID: 15301302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization to cross-reactive carbohydrate determinants in 2 patients with Hymenoptera venom allergy and alcoholic cardiomyopathy.
    Valcarcel MA; Vidal C; Armisén M; Rodríguez V; Gonzalez-Quintela A
    J Allergy Clin Immunol; 2012 Oct; 130(4):1001-3. PubMed ID: 22901863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.